The use of anti-interleukin-12/23 agents and major adverse cardiovascular events.
Department of Dermatology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA. mbigby@bidmc.harvard.edu
Michael
M
Bigby